Kite Pharma vs Oryon Cell Therapies
Kite Pharma vs Oryon Cell Therapies, compared side by side on 12 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Kite Pharma is on 66/100 and Oryon Cell Therapies on 62/100.
Where each one leads
Kite Pharma
- our overall score: 66/100 against 62/100
- agent readiness: 35/100 against 22/100
- funding raised: $421M against $21.0M
Oryon Cell Therapies
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Kite Pharma | Oryon Cell Therapies |
|---|---|---|
| What it is | Biotechnology company developing and commercializing cell therapies for cancer treatment. | Clinical-stage biotechnology company developing autologous neuron replacement medicines for neurodegenerative disorders. |
| Category | Biotechnology, Pharmaceuticals, Oncology, Cell Therapy | Biotechnology, Health, Neuroscience, Cell Therapy |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2009 | Not published |
| Headquarters | Santa Monica, United States | Belmont, USA |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Kite Pharma | Oryon Cell Therapies |
|---|---|---|
| Total funding | $421M | $21.0M |
| Latest round | Venture | Series A |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Kite Pharma | Oryon Cell Therapies |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 66/100 | 62/100 |
| Traction | 40/100 | 38/100 |
| Team | 80/100 | Not published |
| Search visibility | 15/100 | 19/100 |
| Quality | 90/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (35/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 62/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Kite Pharma | Oryon Cell Therapies |
|---|---|---|
| CDN | Cloudflare | Not detected |
| Frameworks | Tailwind CSS, Bootstrap | Not detected |
| Analytics | Google Tag Manager | Not detected |
Kite Pharma vs Oryon Cell Therapies: common questions
Which is better, Kite Pharma or Oryon Cell Therapies?
On our 0-100 score Kite Pharma rates higher (66/100 against 62/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 12 data points above: read the rows that match what you are buying for.
How do Kite Pharma and Oryon Cell Therapies compare on the numbers?
Kite Pharma leads on our overall score (66/100 against 62/100), agent readiness (35/100 against 22/100), funding raised ($421M against $21.0M).
Read the full Kite Pharma review and pricing or the Oryon Cell Therapies review and pricing. You can also browse other Kite Pharma alternatives we track.